✦ LIBER ✦

Docetaxel versus supportive care in previously treated patients with non-small cell lung cancer (NSCLC): Analysis of quality of life and clinical benefit parameters in a randomized trial

✍ Scribed by Gralla, R.J; Shepherd, F.A; Kim, Y.P; Bizzari, J.P

Book ID: 118570494
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 91 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80949-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase III Trial of Pemetrexed

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

✍ Hanna, N.; Shepherd, F. A.; Fossella, F. V.; Pereira, J. R.; De Marinis, F.; von 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 229 KB

A prospective randomized trial of Taxote

A prospective randomized trial of Taxotere versus best supportive care (BSC) in patients with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy: Survival update

✍ Shepherd, F; Dancey, J; Ramlau, R; Mattson, K; Gralla, R; Kim, Y; Berille, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Randomized study of taxotere (TAX) versu

Randomized study of taxotere (TAX) versus best supportive care (BSC) in non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy

✍ F. Shepherd; R. Gralla; R. Ramlau; K. Mattson; B. Bergman; P. Kraszko; R. Rudd; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Quality of life assessment of second-lin

Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial

✍ Dancey, J 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 178 KB

A multicenter, randomized, phase III stu

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

✍ Roszkowski, Kazimierz; Pluzanska, Anna; Krzakowski, Maciej; Smith, Alexander Pet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

PCN58 A COST UTILITY ANALYSIS OF ERLOTIN

PCN58 A COST UTILITY ANALYSIS OF ERLOTINIB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)

✍ PA Bradbury; R Jang; P Isogai; R Ng; N Mittmann; W Evans; FA Shepherd; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB